Craniofacial Muscles

16 Spastic Facial Muscle Disorders
319
Jankovic J, Schwartz KS (1993) Longitudinal experience with botulinum toxin injections for treatment
of blepharospasm and cervical dystonia. Neurology 43(4):834–836
Jankovic J, Stone L (1991) Dystonic tics in patients with Tourette’s syndrome. Mov Disord
6(3):248–252
Jankovic J, Havins WE, Wilkins RB (1982) Blinking and blepharospasm. Mechanism, diagnosis,
and management. JAMA 248(23):3160–3164
Jankovic J, Vuong KD, Ahsan J (2003) Comparison of ef fi cacy and immunogenicity of original
versus current botulinum toxin in cervical dystonia. Neurology 60(7):1186–1188
Jannetta PJ (1983) Hemifacial spasm: treatment by posterior fossa surgery. J Neurol Neurosurg
Psychiatry 46(5):465–466
Jannetta PJ, Abbasy M, Maroon JC, Ramos FM, Albin MS (1977) Etiology and de fi nitive microsurgical
treatment of hemifacial spasm. Operative techniques and results in 47 patients.
J Neurosurg 47(3):321–328
Jedynak CP, Pal fi S, Vidailhet M, Kullmann B (1993) Hemifacial spasm treated with botulinum
toxin. Rev Neurol 149(3):202–206
Jordan DR, Anderson RL, Digre KB (1990) Apraxia of lid opening in blepharospasm. Ophthalmic
Surg 21(5):331–334
Jost WH, Blumel J, Grafe S (2007) Botulinum neurotoxin type A free of complexing proteins
(XEOMIN) in focal dystonia. Drugs 67(5):669–683
Kahn L, Jordaan H (2001) The swallowing and voicing characteristics of pharyngeal dystonia:
a single case report. S Afr J Commun Disord 48:21–31
Kalkanis SN, Eskandar EN, Carter BS, Barker FG, II (2003) Microvascular decompression surgery
in the United States, 1996 to 2000: mortality rates, morbidity rates, and the effects of
hospital and surgeon volumes. Neurosurgery 52(6):1251–1261; discussion 1261–1262
Kalra HK, Magoon EH (1990) Side effects of the use of botulinum toxin for treatment of benign
essential blepharospasm and hemifacial spasm. Ophthalmic Surg 21(5):335–338
Kemp LW, Reich SG (2004) Hemifacial Spasm. Curr Treat Options Neurol 6(3):175–179
Kennedy RH, Bartley GB, Flanagan JC, Waller RR (1989) Treatment of blepharospasm with
botulinum toxin. Mayo Clin Proc 64(9):1085–1090
Krack P, Marion MH (1994) “Apraxia of lid opening,” a focal eyelid dystonia: clinical study of 32
patients. Mov Disord 9(6):610–615
Kraft SP, Lang AE (1988) Botulinum toxin injections in the treatment of blepharospasm, hemifacial
spasm, and eyelid fasciculations. Can J Neurol Sci 15(3):276–280
Kulisevsky J, Marti MJ, Ferrer I, Tolosa E (1988) Meige syndrome: neuropathology of a case. Mov
Disord 3(2):170–175
Lepore V, Defazio G, Acquistapace D et al (1995) Botulinum A toxin for the so-called apraxia of
lid opening. Mov Disord 10(4):525–526
Levin H, Reddy R (2000) Clozapine in the treatment of neuroleptic-induced blepharospasm:
a report of 4 cases. J Clin Psychiatry 61(2):140–143
Linder JS, Edmonson BC, Laquis SJ, Drewry RD Jr, Fleming JC (2002) Skin cooling before periocular
botulinum toxin A injection. Ophthal Plast Reconstr Surg 18(6):441–442
Marti-Fabregas J, Montero J, Lopez-Villegas D, Quer M (1997) Post-irradiation neuromyotonia in
bilateral facial and trigeminal nerve distribution. Neurology 48(4):1107–1109
Mauriello JA Jr, Dhillon S, Leone T, Pakeman B, Mostafavi R, Yepez MC (1996) Treatment selections
of 239 patients with blepharospasm and Meige syndrome over 11 years. Br J Ophthalmol
80(12):1073–1076
Mauriello JA Jr, Carbonaro P, Dhillon S, Leone T, Franklin M (1998) Drug-associated facial
dyskinesias–a study of 238 patients. J Neuroophthalmol 18(2):153–157
Mauriello JA Jr, Keswani R, Franklin M (1999) Long-term enhancement of botulinum toxin injections
by upper-eyelid surgery in 14 patients with facial dyskinesias. Arch Otolaryngol Head
Neck Surg 125(6):627–631
McCann JD, Gauthier M, Morschbacher R et al (1999) A novel mechanism for benign essential
blepharospasm. Ophthal Plast Reconstr Surg 15(6):384–389